$12.15
-0.90 (-6.90%)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
CAPS Rating:
A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.
RSS Headlines
Fool UK